Picture of ANI Pharmaceuticals logo

ANIP ANI Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: ANI Pharmaceuticals Announces The FDA Approval And Launch Of Naproxen Delayed-Release Tablets, USP

July 2 (Reuters) - ANI Pharmaceuticals Inc  ANIP.O :
    * ANI PHARMACEUTICALS ANNOUNCES THE FDA APPROVAL AND LAUNCH
OF
NAPROXEN DELAYED-RELEASE TABLETS, USP
    * ANI PHARMACEUTICALS INC - U.S. ANNUAL SALES FOR NAPROXEN
TABLETS
APPROXIMATELY $36.7 MILLION

Source text for Eikon:  ID:nGNX5KnVRC 
Further company coverage:  ANIP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on ANI Pharmaceuticals

See all news